Eran Broshy sold $590K of Theravance Biopharma (TBPH)

Executed Nov 26 2025, disclosed Dec 1 2025, 5 days later.

Value, as filed

$590K

29,501 sh across 2 lots

Executed

Nov 26 2025

the trade date, as filed

Disclosed

Dec 1 2025

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

EB Eran Broshy Director profile →

Eran Broshy (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales, 1 filed past the two-business-day deadline), most often in Theravance Biopharma, Inc. (TBPH). The largest single filing was $1.1M of TBPH (59,000 sh across 3 lots, as filed), executed Nov 11 2025.

The name

TBPH Theravance Biopharma, Inc. TBPH · Healthcare · 10 filings in 24 months ticker →

Healthcare · Theravance Biopharma, Inc., a biopharmaceutical company, develops and commercializes medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Eran Broshy in TBPH

TBPHSALE Theravance Biopharma, Inc. $1.1M
59,000 sh across 3 lots
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET TBPHSALE Theravance Biopharma, Inc. $809K
45,000 sh across 3 lots
Exec Nov 11 2025
Filed Nov 14 2025 · 5:30 PM ET †